Open Access757 Histologic Improvement With Vedolizumab vs. Adalimumab in Ulcerative Colitis: Results From VARSITY
Author(s) -
Laurent PeyrinBiroulet,
Jean–Frédéric Colombel,
Edward V. Loftus,
Silvio Danese,
Brihad Abhyankar,
Jingjing Chen,
Raquel Rogers,
Richard A. Lirio,
Jeffrey D. Bornstein,
Bruce E. Sands,
Stefan Schreiber
Publication year - 2019
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000592564.74380.03
Subject(s) - vedolizumab , medicine , ulcerative colitis , adalimumab , placebo , gastroenterology , surgery , pathology , tumor necrosis factor alpha , disease , alternative medicine